Novel Treatment Options for Inflammatory Bowel Disease
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 66 (9) , 1179-1189
Abstract
The aetiology of inflammatory bowel disease (IBD) is complex and many aspects still remain unclear. However, significant progress has been made in understanding the pathogenesis of chronic...Keywords
This publication has 26 references indexed in Scilit:
- Progressive Multifocal Leukoencephalopathy in a Patient Treated with NatalizumabNew England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple SclerosisNew England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's DiseaseNew England Journal of Medicine, 2005
- Progressive multifocal leukoencephalopathy in transplant recipientsTransplant International, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- Is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?Alimentary Pharmacology & Therapeutics, 2002
- An ascending dose trial of a humanized A4B7 antibody in ulcerative colitis (UC)Gastroenterology, 2000
- Lymphocyte Homing and HomeostasisScience, 1996
- Mechanisms underlying neutrophil adhesion to apical epithelial membranes.Gut, 1996
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994